Abstract
Mice with the recessive motheaten (me) or the allelic viable motheaten (mev) mutations express a severe autoimmune and immunodeficiency syndrome. We have shown that the basic defect in these mice involves lesions in the gene which encodes haematopoietic cell phosphatase (HCP). These mice thus provide excellent models for investigating the roles of phosphatases in haematopoiesis and the nature of the genetic and cellular events linking impaired haematopoiesis to severe immunodeficiency and expression of systemic autoimmunity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Green, M.C., Shultz, L.D. Motheaten, an immunodeficient mutant of the mouse. J. Hered. 66, 250–258 (1975).
Sidman, C.L., Shultz, L.D. & Unanue, E.R. The mouse mutant “motheaten”. I. Development of lymphocyte populations. J. Immunol. 121, 2392–2398 (1978).
Shultz, L.D., Coman, D.R., Bailey, C.L., Beamer, W.G. & Sidman, C.L. “Viable Motheaten”, a new allele at the Motheaten locus. I. Pathology. Am. J. Pathol. 116, 179–192 (1984).
Greiner, D.L. et al. Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of the development of prothymocytes, B lineage cells and terminal deoxynucleotidyl-transferase-positive cells. J. exp. Med. 164, 1129–1144 (1986).
Davidson, W.F., Morse, H.C., Sharrow, S.D. & Chused, T.M. Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes. J. Immunol. 122, 884–891 (1979).
Sidman, C.L., Shultz, L.D. & Unanue, E.R. The mouse mutant “motheaten”. II. Functional studies of the immune system. J. Immunol. 121, 2399–2404 (1978).
Sidman, C.L., Shultz, L.D., Hardy, R., Hayakawa, K. & Herzenberg, L.A. Production of immunoglobulin isotypes by Ly–1+ B cells in viable motheaten and normal mice. Science 232, 1423–1425 (1986).
Clark, E.A., Shultz, L.D. & Pollack, S.B. Mutations in mice that influence natural killer (NK) cell activity. Immunogenet. 12, 601–613 (1981).
Koo, G.C., Manyak, C.L., Dasch, J., Ellingsworth, L. & Shultz, L.D. Suppressive effects of monocytic cells and TGF–beta on NK differentiation in autoimmune viable motheaten mutant mice. J. Immunol. 147, 1194–1200 (1991).
McCoy, K.L., Neilson, K. & Clagett, J. Spontaneous production of colony-stimulating activity by splenic MAC–1 antigen-positive cells from autoimmune motheaten mice. J. Immunol. 132, 272–276 (1984).
Hayashi, S.I., Witte, P.L., Shultz, L.D. & Kincade, P.W. Lymphohemopoiesis in culture is prevented by interaction with adherent bone marrow cells from mutant viable motheaten mice. J. Immunol. 140, 2139–2147 (1988).
Yi, T., Cleveland, J.L. & Ihle, J.N. Protein tyrosine phosphatase containing SH2 domains. Characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12–p13. Molec. cell Biol. 12, 836–846 (1992).
Plutzky, J. et al. Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6). Genomics 13, 869–872 (1992).
Shen, S-H., Bastien, L., Posner, R.I. & Chretien, P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 352, 736–739 (1991).
Matthews, R.J., Bowne, D.B., Flores, E. & Thomas, M.L. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Molec. cell Biol. 12, 2396–2405 (1992).
Plutzky, J., Neel, B.G. & Rosenberg, R.D. Isolation of an src homology 2-containing tyrosine phosphatase. Proc. natn. Acad. Sci. U.S.A. 89, 1123–1127 (1992).
Sidman, C.L., Marshall, J.D. & Allen, R.D. Murine “viable motheaten” mutation reveals a gene critical to the development of both B and T lymphocytes. Proc. natn. Acad. Sci. U.S.A. 86, 6279–6282 (1989).
Mount, S.M. A catalogue of splice junction sequences. Nucl. Acid Res. 10, 459–472 (1982).
Weatherall, D.J. The New Genetics and Clinical Practice 2nd edn 80–81 (University Press, Oxford, 1985).
Yi, T., Gilbert, D.J., Jenkins, N.A., Copeland, N.G. & Ihle, J.N. Assignment of a novel protein tyrosine phosphatase gene (Hcph). Genomics 14, 793–795 (1992).
Hunter, T. Protein-tyrosine phosphatase: the other side of the coin. Cell 58, 1013–1016 (1989).
Yarden, Y. & Ullrich, A. Growth factor receptor tyrosine kinases. Ann. Rev. Biochem. 57, 443–478 (1988).
Pawson, T. & Bernstein, A. Receptor tyrosine kinases: genetic evidence for their role in Drosophila and mouse development. Trends Genet. 6, 350–356 (1990).
Cool, D.E., Tonks, N.K., Fischer, E.H. & Krebs, E.G. Expression of a human T-cell protein-tyrosine-phosphatase in baby hamster kidney cells. Proc. natn. Acad. Sci. U.S.A. 87, 7280–7284 (1990).
Ramponi, G., Ruggiero, M. & Rauyei, G. Overexpression of a synthetic phospho-tyrosine protein phosphatase gene inhibits normal and transformed cell growth. Int. J. Cancer 51, 652–656 (1992).
Brown-Shimer, S., Johnson, K.A., Hill, D.E. & Bruskin, A.M. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res. 52, 478–482 (1992).
Koch, C.A., Anderson, D., Moran, M.F., Ellis, C. & Pawson, T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668–674 (1991).
Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & Rutter, W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299 (1979).
Chomczynski, P. & Sacchi, N.A. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159 (1987).
Sambrook, J., Fritsch, E.F. & Maniatis, T. in Molecular Cloning: A Laboratory Manual 2nd edn (Cold Spring Harbor Laboratory Press, New York, 1989).
Winship, P.R. An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucl. Acid Res. 17, 1266 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wo Tsui, H., Siminovitch, K., de Souza, L. et al. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 4, 124–129 (1993). https://doi.org/10.1038/ng0693-124
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0693-124
This article is cited by
-
Ets-2 deletion in myeloid cells attenuates IL-1α-mediated inflammatory disease caused by a Ptpn6 point mutation
Cellular & Molecular Immunology (2021)
-
Extracellular signal-regulated kinase 1/2 is required for complement component C1q and fibronectin dependent enhancement of Fcγ- receptor mediated phagocytosis in mouse and human cells
BMC Immunology (2020)
-
Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase
Arthritis Research & Therapy (2020)
-
The E3 ligases Itch and WWP2 cooperate to limit TH2 differentiation by enhancing signaling through the TCR
Nature Immunology (2018)
-
CD45-mediated control of TCR tuning in naïve and memory CD8+ T cells
Nature Communications (2016)